The problem under discussion is best described by an illustrative example. A woman was referred for advice and management midway through her fourth pregnancy. She had one healthy son, her third born. Her first two babies (1 male, 1 female) had both died on the third day of life. Each had seemed normal at birth, but had become drowsy on the second day and then unconscious. She had already decided that there must be a high risk of a similar occurrence in this pregnancy, but she wanted the pregnancy to continue whatever the risk. She hoped we might be able to diminish the risk by some means.
Autosomal recessive inheritance of some metabolic disease was suspected. Informnation about the babies who died revealed only that they did not die of hypoglycaemia, hypocalcaemia, cerebral haemorrhage, or gross cerebral malformation. The task set us by this woman was therefore the management of a newborn baby who was believed to have a 1 in 4 risk of suffering from a rapidly fatal inborn error of metabolism of unknown type. This clinical problem confronts our unit two or three times each year and this paper describes the plan of management developed.
The unit has been working on inborn errors of metabolism for the last 3 years. Though Using this regimen, a normal baby whose investigation turns out (in retrospect) to have been unnecessary will be established on a normal protein intake by the age of 4 days and will have had a venous blood sample taken on only two or three occasions.
Diagnosis of a known inborn error of metabolism leads immediately to institution of the appropriate method of treatment-if one exists.
Some babies may become ill or develop serious abnormalities in laboratory tests without the tests revealing the underlying cause. In this circumstance we use a series of empirical therapeutic measures in addition to symptomatic treatment (e.g. correction of hypoglycaemia, hypocalcaemia, or acidosis, and ventilatory assistance).
(1) Provision of calories at, or in excess of maximal estimated requirement, as dextrose-this generally means 20% dextrose intravenously. This is done to minimize catabolism, and on the assumption that a defect may exist in the metabolism of fat or protein.
(2) Parenteral administration of pharmacological (100 to 1000 times physiological) doses of all those vitamins which are free of toxic effects in the short term-pyridoxine, thiamine, riboflavin, nicotinic acid, vitamin B12, folic acid, and ascorbic acid. The known vitamin dependency states (Rosenberg, 1969) provide the argument for this step.
(3) Exchange transfusion is employed if clinical and/or serious biochemical deterioration occurs despite the above measures, on the assumption that it may remove toxic metabolites. If a definite improvement is achieved this procedure is repeated once, or exceptionally, twice. It is used merely to buy time to allow a more permanent way of controlling the metabolic fault to be found. Results This plan has been used in 6 babies. 4 proved to be normal. 3 of these were sent home on normal feedings on the fifth or sixth day. 1 baby was shown to have a slightly raised level of blood ammonia (180 ,ug/100 ml) and was treated with a restricted protein intake for 10 days before being discharged breast fed. He subsequently proved to have normal protein tolerance.
The most successful case is described elsewhere in this issue (Danks, Tippett, and Zentner, 1974) .
The past obstetric history of that case was used above to introduce this paper. The diagnosis of citrullinaemia was made by 24 hours of age. Treatment by protein restriction from birth has been very successful and his normal clinical condition at 6 months of age contrasts with the deaths of his sibs and of all 3 acutely ill babies previously described with this condition.
The last baby was born to a woman with 4 healthy children whose last 3 successive babies had died of acute hepatic necrosis in the first fortnight of life. Acidosis and hypoglycaemia had been the first abnormalities in each baby.
The baby studied was already acidotic and hypoglycaemic at 4 hours of age. The regimen described was started promptly. Exchange transfusion was employed at 18 hours of age, partly because the serum bilirubin was rising rapidly. He then progressed well for 5 days during which he was weaned off intravenous dextrose onto oral dextrose, and then oral dextrose plus medium chain triglyceride oil.
On the second day after the fat was started (day 7), acidosis, drowsiness, and a remarkable red, raw tongue developed. The massive doses of vitamins had been reduced to near physiological levels when the intravenous catheter had been removed on day 5. Intravenous dextrose was restarted along with large intravenous doses of vitamins B1, B2, B5, and B6. The range of tests we use is clearly inadequate to cover all possible inborn errors of metabolism. We plan to add gas-liquid chromatography of short chain fatty acids and paper chromatography of amines to the repertoire shortly, and we are also working up mass spectrometry methods in gasliquid chromatography. 
